SAN FRANCISCO@JPM

12-15 Jan |

Book your meeting

Accelerating new therapy adoption
↳ by matching patients with therapies

Cancer4D  FOR MEDICAL ONCOLOGISTS

Medical images detect tumors. What if they helped clinicians look ahead too? 

Our latest conference contribution

What if her cancer becomes curable?

Matching therapies to patients for faster access

10% faster patient access could save thousands of lives

STANDARD CARE
Tumor
NEW THERAPY
No tumor

WE NEED TO CHANGE THESE STATISTICS

Hundreds of thousands of breast cancer patients are waiting on clinical uptake

Already 10% faster clinical uptake has significant effect on patient outcomes 

0 years

is too long waiting time for getting access to approved therapies

Based on public data for Herceptin

+0 patients

could be treated earlier with 10% faster clinical uptake 

+0 patients

could benefit from life-saving therapies

Cancer4D: New approach for accelerating clinical uptake with GenAI

So, what can we do?

Why now? This 4D GenAI technology is coming fresh out of recent AI research advancements 

Why Ai:leen Health? We pioneered AI in automotive, now we re-use our specialist competence for cancer patients

Sometimes diesease progresses slow, sometimes aggressive (e.g. triple-negative breast cancer)

We predict the progression speed and treatment response, informing doctors in advance about how to treat the disease

We trained Cancer4D with breast and brain images, and are extending our capabilities to lung and prostate

Learn more for

Healthcare providers, pharma companies and regulatory authorities

Go to our pages with more information
Article

Regulatory innovation for 4D generative AI

8. December 2025
>> Read more
Article

Validation of oncology virtual Phase III trials

10. December 2025
>> Read more
Article

4D generative AI in regulatory terms for EMA

11. December 2025
>> Read more

“As a young woman, the risks of breast and interval cancer can be worrying. However, knowing that Aileen Health enables radiologists to not only detect breast cancer but also evaluate future risks of interval cancer gives me peace of mind. The thorough approach to early detection and prevention helps me feel more confident and reassured about the health of my family, friends and myself.”

Matilda Åboge Eriksson
Woman

This is a wonderful product, especially for younger women in high risk groups, who wants to wait with medical procedures until the children are born.

Liza
Patient advocate

It is a great relief for women to hear that there are no signs of cancer for the next 2 years. Especially for women with a family history of cancer.

Mary
Breast radiologist

TESTIMONIALS

Ai:leen Health started from conversations with women

Together with providers and pharma, we can make sure women stop dying from the disease.

OUR TEAM

Scientific, technical, and business

Our team has decades of experience in AI and working with healthcare systems

Contact us now

Our next stops

Meet us in person when we are on the road

 We’d love to meet you in person!

  1. 05 Jan, 26 - 09 Jan, 26

    Vienna, Austria

    Office hackathon

  2. 12 Jan, 26 - 16 Jan, 26

    San Francisco, CA, USA​

    Visiting JP Morgan Health

  3. 05 Feb, 26 - 06 Feb, 26

    Munich, Germany

    DxPx Europe

Get notified when we have more news

Together, we can revolutionize healthcare. Subscribe to our updates and be the first to know when and where Ai:leen is available.

Newsletter

You are about to download our 2025 ESMO AI poster “Predicting solid-tumor behaviour over time with explainable gen AI for precision oncology”

By submitting this form, you agree to our privacy policy